Abstract:
Goal: We previously demonstrated that near-infrared spectroscopy in vivo presents spectral features at 895 and 861 nm that accurately classify Alzheimer’s disease, mild cognitive impairment, and age-matched control subjects. Our purpose here is to associate the 895 nm signal with β-amyloid. Methods: We applied our feature selection technique to subjects with and without …